Patents
Patents for C07K 4 - Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof (2,102)
05/2011
05/17/2011US7943728 Polypeptides and/or polynucleotides selective for alpha v beta 3 integrin; osteoporosis, bone tumor or cancer growth, angiogenesis, Paget's disease, rheumatic arthritis, osteoarthritis; culture biosynthesis and chromatographic separation
05/10/2011US7939220 Proton-translocating retinal protein
05/05/2011US20110104263 Claudin-4 binding peptides, compositions and methods of use
05/04/2011EP2316849A2 Polypeptides comprising RER, derivatives and uses thereof
04/2011
04/28/2011US20110097360 Streptococcus pneumoniae pilus antigens
04/26/2011CA2201482C Novel ectoparasite saliva proteins and apparatus to collect such proteins
04/21/2011US20110092445 Amyloid ß peptide analogues, oligomers thereof, processes for preparing and composi-tions comprising said analogues or oligomers, and their uses
04/19/2011US7928076 Polypropylene binding peptides and methods of use
04/19/2011US7927600 Anti-allergic pharmaceutical composition containing at least one allergen and at least one antihistamine compound
04/13/2011EP2307444A1 Analysis of lactobacillus acidophilus la-5 signal interference molecules
04/12/2011US7923543 Nucleic acid and corresponding protein entitled 162P1E6 useful in treatment and detection of cancer
04/07/2011DE102008005097B4 Antitumoraler Cyclodepsipeptide, deren Herstellung und Verwendung Antitumoral cyclodepsipeptides, their preparation and use
04/06/2011EP2303909A1 Iqgap3 epitope peptides and vaccines containing the same
04/05/2011US7919099 Epitope peptides derived from vascular endothelial growth factor receptor 1 and vaccines containing these peptides
03/2011
03/24/2011US20110070155 Anti-CD74 Immunoconjugates and Methods
03/23/2011EP2298789A1 Mammalian genes; related reagents and methods
03/23/2011CN101987864A Peanut protein active peptide and production process thereof
03/16/2011EP2295064A1 Monoclonal antibody therapy for pancreas cancer
03/16/2011EP1337858B1 A reagent and kit for determining the global coagulability and the hemostatic potential
03/16/2011CN101985644A Momordica charantia polypeptide, preparation method and application thereof
03/03/2011US20110053182 Diagnosis of pre-cancerous conditions using pcdgf agents
03/01/2011US7897158 Recombinant toxin fragments
02/2011
02/24/2011US20110045017 Hiv vaccine for mucosal delivery
02/09/2011CN101970456A Tag peptide and use thereof
02/08/2011US7884180 binds formyl peptide receptor-like 1 (FPRL1); useful for treating disorders associated with G-protein coupled receptor activation
02/08/2011US7883710 Peptide vaccines against Group A streptococci
01/2011
01/27/2011US20110020335 Treatment of Cancers Expressing p95 ErbB2
01/26/2011EP1303186B1 Medicinal uses of mu-opioid receptor agonists
01/19/2011EP1411962B1 Monoclonal antibody therapy for pancreas cancer
01/19/2011CN101951936A Methods for prevention and treatment of acute renal injury
01/13/2011WO2011005219A1 Novel mdm2 binding peptides and uses thereof
01/13/2011WO2010135431A3 Compositions, devices, and methods related to prostate-specific membrane antigen
01/11/2011US7868134 Immunogenic peptides derived from sclerostin
01/04/2011US7862815 Methods for inhibiting angiogenesis with inhibitors of proadrenomedullin N-terminal 20 peptide (PAMP)
12/2010
12/28/2010US7858679 Polymeric compositions and related methods of use
12/16/2010WO2010076654A3 Cysteine-free technetium (tc) or rhenium (re) chelating peptide tags and their use
12/15/2010CN101918435A Streptococcus m protein, immunogenic fragments, nucleic acids and methods of use
12/15/2010CN101418034B Method for extracting jatropha curcas seed oil protein
12/15/2010CN101343312B Process for the separation of oil body protein of jatopha curcas seeds
12/14/2010US7851597 lyases enzymes obtained from transformed plant tissue expressing polynucleotide that encodes the polypeptide; improved ethanol biosynthesis, stalk and nodal strength
12/08/2010EP1438329B1 Biologically active peptides and their use for repairing injured nerves
12/07/2010US7847058 Method of modulating cell survival, differentiation and/or synaptic plasticity
12/07/2010US7846451 Chimeric outermembrane polypeptide for use as tool in diagnosis and treatment of parasitic infection
12/02/2010US20100303866 Immunogenic peptides and their use in immune disorders
12/01/2010EP2255832A2 IFBM's to promote attachment of target analytes
11/2010
11/25/2010US20100298239 Peptide with multiple epitopes
11/25/2010US20100298209 Compounds for preventing or treating a viral infection
11/23/2010US7838632 Maize cellulose synthases and uses thereof
11/18/2010US20100291104 Bordetella outer-membrane protein antigens and methods of making and using the same
11/09/2010US7829297 selecting therapy for a human subject having a solid epithelial tumor that overexpresses ErbB2 comprising determining whether the tumor expresses p95ErbB2; reversible dual tyrosine kinase inhibitor of both ErbB2 and epidermal growth factor receptor
11/09/2010US7829064 antigen binding molecules conjugated to lipids, polymer carriers, micelles, nanoparticles or mixtures and effectors, used for therapy of diagnosis
11/04/2010WO2010125910A1 Collagen peptide composition having good blood transfer properties, and food and drink containing same
11/04/2010US20100279378 MEK Ligands and Polynucleotides Encoding MEK Ligands
11/04/2010CA2759424A1 Collagen peptide composition having good ability to enter the blood and food or beverage containing the same
11/03/2010EP1606232B1 Improved extraction process
11/02/2010US7824687 Clustered multi-antigenic carbohydrate constructs, methods for their preparation, and uses thereof
10/2010
10/28/2010WO2010122298A1 Materials based on filamentous peptide - or protein-based structures
10/21/2010US20100267638 Exosite-directed thrombin inhibitors
10/19/2010CA2437081C Protein hydrolysates enriched in peptides having a carboxy terminal proline residue
10/13/2010CN101134772B Method for separating membrane protein of sucking sperm rear head and uses thereof
10/05/2010US7807629 topical administering a bradykinin B2 receptor agonist; without side-effects; controlling intraocular pressure
09/2010
09/23/2010WO2010031988A3 Polypeptides substrates of lrrk2 and uses thereof
09/23/2010US20100239588 The functional epitope of osteopontin, the anti-osteopontin monoclonal antibody and use thereof
09/22/2010EP2230245A1 Peptides having pharmacological activity for treating disorders associated with altered cell migration, such as cancer
09/16/2010DE102009047562A1 Agent comprises peptide compounds, useful for capturing or inhibiting avian influenza virus and in biosensor for detecting or capturing avian influenza virus
09/15/2010EP2228387A2 Polypeptides derived from amyloid precursor peptide (app) and their uses
09/14/2010US7795387 detecting the decreased transcription of messenger RNA transcribed from an RDCVF1 or RDCVF2 polypeptide, in the eye of a human, wherein said decreased transcription is diagnostic of such human's suffering from retinal dystrohy
09/14/2010US7795378 Erectile dysfunction
09/14/2010US7795225 inhibitors of chondrosarcoma cell growth that are useful as anti-cancer and anti-tumor agents; inhibitors are peptides having sequences related to cleavage regions of the proenzyme forms of matrix metalloproteinases and that can inhibit the activity of matrix metalloproteinases
09/14/2010US7794962 capable of processing intron-containing eukaryotic genes, and also can carry out post-translational processing steps such as glyclosylation and protein folding
09/07/2010US7790861 Nucleotide sequences coding polypeptide for use in the diagnosis of cancer in mammals
09/07/2010CA2450871C Assay for identifying inhibitors of hiv rt dimerization
09/01/2010CN101092449B Technique for preparing collagen of freshwater fish skin
08/2010
08/31/2010US7786086 at least one aromatic amino acid (phenylalanine); hollow and fibrillar peptide; macroscopic and microscopic articles; self-assembled; 9-fluorenylmethyloxycarbonyl (Fmoc) and benzyloxycarbonyl (Cbz); slow release of drug, nucleic acid molecule or a polypeptide; antibody
08/31/2010US7786077 Insulins combinations
08/31/2010US7786072 Stabilized compounds having secondary structure motifs
08/31/2010US7785589 biological fragments comprising polypeptides, in a combination with phosphatides, used for for immunization or treatment of ischemic cardiovascular disorders, in humans
08/31/2010US7785588 Anti-neurturin receptor-A antibody compositions comprising cytokines or neurotrophic factors
08/31/2010US7785567 treatment of hypercholesterolemia or cardiovascular disease associated with atherosclerosis by administration of Growth Hormone Releasing Peptides to patient; reducing blood plasma cholesterol levels; modulating expression of scavenger receptor CD36 and genes involved in cellular cholesterol efflux
08/31/2010CA2217871C Altered polypeptides with increased half-life
08/24/2010CA2474031C Heterocyclic tripeptides as hepatitis c inhibitors
08/12/2010US20100203001 Process for forming disulfide bridges
08/04/2010EP2213680A1 Peptides having pharmacological activity for treating disorders associated with altered cell migration, such as cancer
08/03/2010US7767787 Substance for obtaining highly effective tumor medications as well as a process
08/03/2010US7767786 Neural regeneration peptides and methods for their use in treatment of neural injury or degeneration
07/2010
07/28/2010CN101787387A Acid-resistant no-bitterness soybean oligopeptide and production method and application thereof
07/27/2010US7763706 cleaving proteins by enzymatic hydrolysis into peptides, then allowing the peptides to bind to a cation exchange resin, washing the cation exchange resin with an alkaline solution and eluting bound peptides from the resin with water; active compound in drugs, nutraceutical, beverages and food products
07/22/2010US20100184637 Pharmaceutical and/or cosmetic composition containing an active antioxydant principle and cell energy activator
07/20/2010US7759314 Stabilizing collagen VI-deficient dystrophin-associated protein complexes (DAPCs) on the surface of a cell by contacting the cell with an effective amount of a biglycan therapeutic; treatment of muscular dystrophies
07/20/2010US7758863 Replikin peptides in rapid replication of glioma cells and in influenza epidemics
07/20/2010CA2278786C Selection of proteins using rna-protein fusions
07/13/2010CA2262893C Peptides responsive to antibodies against a consensus peptide of the cs4-cfa/i family proteins
07/08/2010WO2010076654A2 CYSTEINE-FREE EFFICIENT TECHNETIUM (Tc) OR RHENIUM (Re) CHELATING PEPTIDE TAGS AND THEIR USE
07/08/2010WO2010033868A3 Ligand-specific non-antibody compounds that inhibit cr2 activation and methods of use thereof
07/08/2010CA2745946A1 Cysteine-free efficient technetium (tc) or rhenium (re) chelating peptide tags and their use
07/07/2010EP2204377A1 Cysteine-free technetium (tc) or rhenium (re) chelating peptide tags and their use
07/01/2010WO2010035292A8 The use of a human monoclonal anti-hcv antibody as a medicament for the therapeutic treatment and prevention of hcv infections
07/01/2010US20100168031 Lat peptides and their use in assays for identifying immunosuppressants
07/01/2010US20100166859 Novel nutraceutical compositions and use thereof
06/2010
06/29/2010US7745588 Antibodies to a paralytic peptide
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 ... 22